Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness

Journal of Thrombosis and Thrombolysis

Volumn 35, Issue 2, 2013, Pages 147-154

  Gross, A Kendall ^a   Dunn, Steven P ^b   Feola, David J ^c   Martin, Craig A ^d   Charnigo, Richard ^e   Li, Zhenyu ^d   Abdel Latif, Ahmed ^d   Smyth, Susan S ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c University of Kentucky   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

Antiplatelet therapy; Clopidogrel; Cohort study and meta analysis; Community acquired pneumonia; Thienopyridine

Indexed keywords

CLOPIDOGREL;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CRITICAL ILLNESS; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PNEUMONIA; SEVERITY OF ILLNESS INDEX; TICLOPIDINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877014506     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0833-4     Document Type: Article

References (32)

1. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594
2. Evangelista V, Manarini S, Dell'Elba G, Martelli N, Napoleone E, Di Santo A, Savi P, Lorenzet R (2005) Clopidogrel inhibits platelet-leukocyte adhesion and platelet dependent leukocyte activation. Thromb Haemost 94:568-577
3. Bayat B, Werth S, Sachs UJH, Newman DK, Newman PJ, Santoso S (2010) Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1. J Immunol 184:3889-3896
4. Danese S, de la Motte C, Reyes BMR, Sans M, Levine AD, Fiocchi C (2004) Cutting Edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol 172:2011-2015
5. Diacovo T, Roth S, Buccola J, Bainton D, Springer T (1996) Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 88:146-157
6. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA (2009) Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol 40:123-134
7. Evangelista V, Dell'Elba G, Martelli N, Amore C, Pecce R, Piccoli A, Manarini S, Totani L. July 2007. Anti-inflammatory effects of clopidogrel in the mouse. Abstract presented at congress of the international society on thrombosis and haemostasis, Geneva, Switzerland
8. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S (2003) Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease[ast]. Clin Pharmacol Ther 73:232-241
9. Hermann A, Rauch BH, Braun M, Schrör K, Weber A-A (2001) Platelet CD40 ligand (CD40L) - subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 12:74-82
10. Antonino MJ, Mahla E, Bliden KP, Tantry US, Gurbel PA (2009) Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting. Am J Cardiol 103:1546-1550
11. Graff J, Harder S, Wahl O, Scheuermann E-H, Gossmann J (2005) Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers[ast]. Clin Pharmacol Ther 78:468-476
12. Steinhubl SR, Badimon JJ, Bhatt DL, Herbert J-M, Lüscher TF (2007) Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med 12:113-122
13. Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP, Claus RA, Bauer M, Lösche W (2009) Antiplatelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets 20:50-57
14. Aslam R, Speck ER, Kim M, Crow AR, Bang KWA, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW (2006) Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-{alpha} production in vivo. Blood 107:637-641
15. Winning J, Neumann J, Kohl M, Claus RA, Reinhart K, Bauer M, Losche W (2010) Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med 38:32-37
16. Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ (2011) Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury. Chest 139:289-295
17. O'Neal HR Jr, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, May AK, Bernard GR, Ware LB (2011) Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med 39:1343-1350
18. Mandell Lionel A, Wunderink Richard G, Anzueto A, Bartlett John G, Campbell GÂD, Dean Nathan C, Dowell Scott F, File J, Thomas M, Musher Daniel M, Niederman Michael S, Torres A, G Whitney Cynthia (2007) Infectious diseases society of America/american thoracic society consensus guidelines on the management of communityâ€acquired pneumonia in adults. Clin Infect Dis 44:S27-S72
19. Jackson ML, Neuzil KM, Thompson W, Shay DK, Yu O, Hanson CA, Jackson LA (2004) The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 39:1642-1650
20. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
21. DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28:105-114
22. Russwurm S, Vickers J, Meier-Hellmann A, Spangenberg P, Bredle D, Reinhart K, Losche W (2002) Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 17:263-268
23. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland H, Werdan K (1995) Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 25:843-851
24. Pitchford SC (2007) Novel uses for antiplatelet agents as anti-inflammatory drugs. Br J Pharmacol 152:987-1002
25. von Hundelshausen P, Weber KSC, Huo Y, Proudfoot AEI, Nelson PJ, Ley K, Weber C (2001) RANTES deposition by platelets triggers monocyte arrest on Inflamed and atherosclerotic endothelium. Circulation 103:1772-1777
26. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS (2001) Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis. J Cell Biol 154:485-490
27. Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T (2004) Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 189:711-716
28. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451
29. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, Ejiri J, Kobayashi S, Hirata K-I, Kawashima S, Yokoyama M (2004) Expression of Toll-like receptors on human platelets. Thromb Res 113:379-385
30. Andonegui G, Kerfoot SM, McNagny K, Ebbert KVJ, Patel KD, Kubes P (2005) Platelets express functional toll-like receptor-4. Blood 106:2417-2423
31. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z (2009) Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 182:7997-8004
32. Lynn MR (1989) Instrument reliability and validity: how much needs to be published? Heart Lung 18:421-423